
PADCEV® (enfortumab vedotin-ejfv) for Advanced Bladder Cancer
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or • PADCEV may be used alone if you:
How Does PADCEV® (enfortumab vedotin-ejfv) Work?
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or • PADCEV may be used alone if you:
PADCEV® is an FDA-approved treatment for locally advanced or metastatic urothelial cancer in the following clinical settings. 1 In combination with pembrolizumab for 1 :
Dosing and Administration | PADCEV® (enfortumab vedotin-ejfv)
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or • PADCEV may be used alone if you:
PADCEV® (enfortumab vedotin-ejfv) | FAQs
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or • PADCEV may be used alone if you:
Possible Side Effects | PADCEV® (enfortumab vedotin-ejfv)
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or • PADCEV may be used alone if you:
PADCEV® (enfortumab vedotin-ejfv) | Resources
WHAT IS PADCEV® (enfortumab vedotin-ejfv)? PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or
PADCEV may cause serious side effects, including: skin reactions, high blood sugar (hyperglycemia), lung problems, nerve problems, eye problems, and leakage of PADCEV out of your vein into the tissues around your infusion site (extravasation).
Clinical Study Results | PADCEV® (enfortumab vedotin-ejfv)
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or • PADCEV may be used alone if you:
PADCEV 是一种处方药物,用于治疗已经扩散或者无法进行手术切除的膀胱癌和尿道癌 (肾盂、输尿管或尿道)成年患者。 • PADCEV 可以与帕博利珠单抗(也称 Keytruda®)联合使用,或者 • PADCEV 也可以在以下条件下单独使用,即您: